Shandong Provincial Hospital
Clinical trials sponsored by Shandong Provincial Hospital, explained in plain language.
-
New weekly shot aims to turn back the clock on prediabetes
Disease control Not yet recruitingThis study tests whether a once-weekly injectable drug called mazdutide can help adults with prediabetes achieve normal blood sugar levels. About 150 participants will receive either a low dose, a higher dose, or a placebo for 24 weeks, along with diet and exercise advice. The ma…
Phase: PHASE4 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a thyroid boost help tiny preemies grow smarter and stronger?
Disease control Not yet recruitingThis trial investigates whether giving a thyroid hormone (levothyroxine) to very small preterm infants with mildly low thyroid function can improve their physical growth and brain development by age two. The study includes infants born weighing under 1500 grams who are small for …
Phase: NA • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy targets tough stomach cancer with liver spread
Disease control Not yet recruitingThis study tests a mix of treatments—including targeted therapy, immunotherapy, chemotherapy, and procedures that block blood flow to tumors or burn them—as a first treatment for people with a specific type of stomach cancer (HER2-high) that has spread to the liver. About 40 part…
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Stroke drug trial aims to boost brain recovery after clot removal
Disease control Not yet recruitingThis study tests whether giving a drug called tirofiban directly into the artery right after a clot is removed can help people recover better from a severe stroke. About 344 adults who had a large-vessel blockage stroke will be randomly assigned to receive the drug or not. The ma…
Phase: PHASE3 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy targets hard-to-treat pancreatic cancer liver spread
Disease control Not yet recruitingThis study tests a new first-line treatment for people with pancreatic cancer that has spread to the liver. The treatment combines chemotherapy delivered directly to the liver with two immunotherapy drugs. The goal is to see if this approach can slow or stop cancer growth. The st…
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Brain-Computer interface boosts stroke recovery in early trial
Symptom relief Not yet recruitingThis study tests whether adding brain-computer interface (BCI) training to standard early rehabilitation helps people recover arm and leg movement after an acute ischemic stroke. Sixty adults aged 18 to 80 with one-sided limb weakness will receive either standard rehab alone or s…
Phase: NA • Sponsor: Shandong Provincial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC